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Abstract
Worldwide resurgence of pertussis necessitates the need for improvement of pertussis vaccines and vaccination strategies.
Since natural infections induce a longer-lasting immunity than vaccinations, detailed knowledge of the immune responses
following natural infection can provide important clues for such improvement. The purpose was to elucidate the kinetics of
the protective immune response evolving after experimental Bordetella pertussis (B. pertussis) infection in mice. Data were
collected from (i) individual analyses, i.e. microarray, flow cytometry, multiplex immunoassays, and bacterial clearance; (ii)
twelve time points during the infection; and (iii) different tissues involved in the immune responses, i.e. lungs, spleen and
blood. Combined data revealed detailed insight in molecular and cellular sequence of events connecting different phases
(innate, bridging and adaptive) of the immune response following the infection. We detected a prolonged acute phase
response, broad pathogen recognition, and early gene signatures of subsequent T-cell recruitment in the lungs. Activation
of particular transcription factors and specific cell markers provided insight into the time course of the transition from innate
towards adaptive immune responses, which resulted in a broad spectrum of systemic antibody subclasses and splenic Th1/
Th17 memory cells against B. pertussis. In addition, signatures preceding the local generation of Th1 and Th17 cells as well as
IgA in the lungs, considered key elements in protection against B. pertussis, were established. In conclusion, molecular and
cellular immunological processes in response to live B. pertussis infection were unraveled, which may provide guidance in
selecting new vaccine candidates that should evoke local and prolonged protective immune responses.
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Introduction
The gram-negative bacterium Bordetella pertussis, the causative
agent of whooping cough (pertussis), accounted for high mortality
rates among infants in the pre-vaccine era. Whole cell and
acellular vaccines have drastically decreased the number of cases
[1]. However, recently resurgence of pertussis in the vaccinated
population has been observed in the USA [2,3] and in European
countries [4,5]. Currently pertussis is still endemic, ranking in the
top-ten of vaccine preventable diseases worldwide, according to
the WHO. Next to improved diagnostics and public awareness,
also strain adaptation and waning immunity are thought to be
responsible for this increase in disease cases [6]. Thus, a call for
vaccines with improved efficacy is evident.
As a main feature of the innate immune response upon B.
pertussis infection in mice the recognition of lipopolysaccharide
(LPS) by TLR4 has been acknowledged [7,8]. This activation of
TLR4 by B. pertussis leads to up-regulation of cytokine gene
expression and recruitment of neutrophils into the lungs [9,10]. It
was found in animal models that B. pertussis infection results in
formation of T-helper (Th) 1 and Th17 cells [11–13]. Since
immunity induced by natural infections provides faster clearance
upon reinfection and is longer lasting compared to both acellular
and whole cell pertussis vaccination [14,15], immune mechanisms
induced upon infection or vaccination have been compared. In
human and murine studies, immunization with whole cell or
acellular pertussis vaccines results predominantly in a Th1 or a
Th2 response, respectively [11,16]. In addition, in both the
intramuscular (human) or subcutaneous (mice) administered
acellular and whole cell pertussis vaccines, the humoral response
is characterized by systemic IgG [17,18], while mucosal immune
responses seem absent. Despite the absence of direct evidence for
correlates of protection against B. pertussis, both Th1 and Th17
type CD4+ T-cells as well as IgA-producing B-cells seem to play an
important role in a protective immune response against B.
pertussis [12,15,19–22]. Since these responses are not induced
by the currently available vaccines [23], but more resemble
responses induced by infection, a better understanding of the
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immune response induced in the host following B. pertussis
infection is needed. Despite knowledge on particular elements of
the immune response generated by a B. pertussis infection, little is
known about the kinetics and sequential relation of these elements.
For this, systems biology can be an important tool, as was shown
for tuberculosis and influenza infection [24–26].
Here, systems biology was applied to elucidate molecular and
cellular events in the different phases of the immune response after
primary B. pertussis infection in a murine model. To this end,
innate and adaptive immune responses were investigated over a
period of 66 days post infection. Gene expression profiles in spleen
and lungs, cytokine profiles in sera, and cellular composition of the
spleen were determined at twelve time points. Furthermore,
cellular and antibody mediated immune responses against B.
pertussis were investigated. Herewith, we revealed a chronological
cascade of immunological processes consisting of recognition,
processing, presentation and clearance of B. pertussis. The
extensive insights into the immune response upon B. pertussis
infection generated in this study may serve as a solid base for
future research on pertussis vaccines and vaccination strategies.
Results
Lung clearance of infected mice
The presence of B. pertussis in lungs of mice was examined
during a period of 28 days post infection (p.i.), providing the
benchmark for this study (Figure 1A). Therefore, mice were
intranasally infected with B. pertussis using a dose of 105 colony
forming units (cfu). Approximately 13% of the intranasal dose was
traceable in the lungs of mice 2 hours p.i. The number of bacteria
remained fairly constant for one day, and increased from the
second day to a maximum 7 days p.i. (107 cfu). Subsequently, a
decrease in the number of bacteria was observed and complete
clearance in 2 out of 3 mice was achieved 28 days p.i. To
determine whether single intranasal infection with B. pertussis
leads to protection, mice were reinfected 56 days after primary
infection (Figure 1B). A similar number of viable bacteria was
detected 4 hours p.i. in lungs of both reinfected and naive mice.
Reinfected mice were able to clear B. pertussis from the lungs
within 2 days p.i., whereas naive mice showed a similar pattern as
observed before. In conclusion, naive mice can clear B. pertussis
from the lungs in about 28 days. Furthermore, mice previously
infected with B. pertussis had developed sterilizing immunity,
which clears the lungs in two days.
Gene expression in lung tissue
The gene expression in lung tissue of infected mice was
monitored over a period of 28 days. In total 558 genes of the
genome were differentially regulated (p-value#0.001, fold ratio
(FR) $1.5): 446 genes were up-regulated and 112 genes were
down-regulated (Figure 2). A complete list of gene names is given
in Table S1. Gene expression profiles changed already 4 hours p.i.
with largest differences at 14 days p.i. (377 responsive genes). The
number of genes with an altered expression had declined 21 and
28 days p.i. However, the expression of many genes had not yet
returned to naive basal levels. Principal component analysis
confirmed the largest differences at 14 days p.i. and the decline at
21 and 28 days p.i. (Figure 3). Interestingly, the time point with
the least changes in gene expression (2 days p.i.) preceded the
increase in cfu in the lungs (Figure 1).
To determine which biological processes were involved,
functional analysis of all 558 genes was performed using DAVID.
Over-representation analysis (ORA) (Benjamini-corrected p-val-
ue#0.05) in GO-BP and KEGG databases resulted in respectively
122 terms and 20 pathways significantly enriched. A selection of
these terms is presented in Figure 4. The selection is based on
immunological relevance and by exclusion of overlapping terms.
Acute phase response and chemotaxis were observed right after
infection (4 hours p.i.) (Figure 2). Subsequently, innate immune
response, phagocytosis, antigen processing and antigen presenta-
tion were initiated (7 days p.i.). Involvement of B-cell mediated
immunity in this stage is mainly demonstrated by the expression of
complement related genes. Eventually, the gene expression
showed initiation of the adaptive immune response, such as
activation of B-cells and T-cells, B-cell receptor (BCR) signaling,
humoral immune response (complement activation) and immuno-
globulin-mediated immunity from 10 until 28 days p.i.
The gene expression data was compared with the BioGPS
database to identify the influx, presence or activation of particular
immunological cells in the lungs (Figure S1). Sixty-one genes,
which are predominantly expressed in macrophages, suggest two
events: (i) triggering of alveolar macrophages 4 hours p.i. and (ii)
recruitment of macrophages in the lungs 7 days p.i. The influx of
macrophages was observed on cellular level using fluorescence
microscopy [27]. In addition, the increased expression of 29 genes
was attributed to the presence of neutrophils in the lungs 4 days
p.i. Moreover, data suggests altered expression of 32, 48 and 17
genes of B-cells, dendritic cells (DCs) and mast cells, respectively, 7
days p.i., and 19 T-cell genes 14 days p.i.
Differentially regulated genes in lung tissue after the infection
with B. pertussis were classified according to function, pathway
and cell type. For ten different groups details are described below.
Cytokines. Twenty-one cytokine-encoding genes were differ-
entially expressed in the lungs during B. pertussis infection
(Figure 5). Sixteen cytokines are associated with a chemotactic
function. The other five genes (Flt3l, Ifng, Il17a, Il17f, Il16)
reflect cytokines involved in the activation of T-cells, such as Th1
and Th17 cells.
Membrane receptors. Forty-six membrane receptors were
identified with altered gene expression (Figure 5). The receptors
were divided in eight groups: cytokine receptors, C-type lectins
(CLRs) [28], Fc-receptors, epithelial cell specific receptors,
including the IgA transporter (pIgR), myeloid-associated immu-
noglobulin-like receptors, semaphorins [29], lymphocyte receptors
(e.g., Pdl1) [30,31] and the mucosal-homing receptor (Itgb7).
Other membrane receptors are collected in one group (Figure 5).
Gene expression profiles of both cytokines and cytokine
receptors enabled early prediction of immune cell recruitment
towards the lungs on transcriptomic level in this study. Increased
expression of Cxcl13 and Ccl20 was followed by the up-regulation
of receptors Cxcr5 and Ccr6. These chemokines lead to the
recruitment of CXCR5+ B-cells, CXCR5+ T-cells, CCR6+ DCs
and CCR6+ Th17 cells into the lungs [32–34]. Likewise, the
expression of Cxcl9, Cxcl10 and Cxcl11, induced by interferon
gamma (IFNc), is associated with recruitment of CXCR3+ T-cells
or CXCR3+ pDCs [35].
Antimicrobial peptides (AMPs). AMPs have defensive
properties against bacterial infections, recruit immune cells and
model subsequent immune responses [36]. Gene expression of
four AMPs was elevated for 21 days p.i. (Figure 6). These four
AMPs recruit neutrophils or protect against respiratory pathogens
[37–40]. Interestingly, the chemokine Cxcl17, primarily expressed
in the lungs, was described as an antimicrobial mucosal chemokine
that recruits DCs and CD14+ monocytes and protects against
pathogenic bacteria [41,42].
Acute phase response. Primary reaction to an infection is
the acute phase response, which leads to the release of pro-
inflammatory cytokines and activation of inflammatory cells.
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Strong up-regulation of 19 genes involved in the acute phase
response was detected at 4 hours p.i. Remarkably, the gene
expression of the acute phase response remained highly expressed
at least until day 28 p.i. (Figure 6).
Pathogen recognition. Enhanced gene expression suggested
activation of TLR4, TLR9, DAI and CLR signaling pathways,
implying pathogen recognition by several ligands of B. pertussis
(Figure 6). The induction of Md-1 and transcription factor Irf5
genes suggested TLR4-signaling upon sensing of LPS [43]. Up-
regulation of Ctsk and the downstream transcription factor Irf7
assumes activation of TLR9 by sensing of unmethylated CpG
sequences in bacterial DNA [44]. In addition, the cytosolic DNA
sensor (DAI) was induced [45]. Elevated gene expression of several
CLRs was noticed, such as Mgl1 and the mouse DC-SIGN-related
proteins Signr7 and Signr8 [46]. Mgl1 recognizes N-acetylga-
lactosamine (GalNAc), which is present in B. pertussis. Mgl1 has
recently been linked to B. pertussis mast cell interaction [47].
Transcription factors. Ten transcription factors were dif-
ferentially expressed in the lungs (Figure 6). These include genes of
factors Pu.1, Shp-1, Nfil3, Syk, Irf5, Irf7 and Irf8. All of these
transcription factors have been designated as regulators of
immunological processes, thereby defining the direction of the
host’s immune response upon bacterial infection [48–54].
Phagocytosis. Six genes representing subunits of NADPH
oxidase (NOX) were activated between 4 hours and 28 days p.i.
(Figure 6). The activation suggests the production of reactive
oxygen species, which are involved in a phagocyte respiratory
burst to assist in the killing of bacteria during phagocytosis [55].
Antigen presentation. Twenty-eight genes representing an-
tigen presentation were up-regulated between 7 and 28 days p.i.
(Figure 6). Results indicate that both antigen presentation via
MHC class I and class II were included. This suggests antigen
presentation to both CD4+ T-helper cells and cytotoxic CD8+ T-
cells (CTLs). In line with these findings, the up-regulation of Cd4
and Ctsw gene expression in lung tissue was observed, which may
indicate presence of Th-cells [56] and CTLs [57], respectively
(Figure S1).
Complement activation. Twelve genes of the complement
system were more abundantly expressed between 7 and 28 days
p.i. (Figure 6). Increased gene expression was observed for the
complement components C1 and C4, which belong to the classical
pathway. In contrast, reduced gene expression of the C1-inhibitor
(Serping1) was observed day 4 p.i. Furthermore, strong up-
regulation of Cfb suggests activation of the alternative complement
pathway.
B-cell receptor (BCR) signaling. Fifteen genes of the BCR
signaling pathway were up-regulated between 7 and 28 days p.i.
(Figure 6). BCR activation was detected by elevated gene
expression of eight downstream proteins (Blnk, Card11, Grb2,
Pik3cd, Plcg2, Prkcb, Rac2 and Vav1). Furthermore, the gene
expression of the BCR signaling pathways indicates a balanced B-
cell response because of an interplay of stimulation by Cd79a and
Ifitm1, and inhibition by FcgrIIb, Lilrb3 (Pirb), Cd22, Cd72 and
Shp-1. These co-inhibitors prevent overstimulation of B-cells [58].
Immunoglobulins. Gene expression associated with anti-
body formation was observed after 4 days p.i. and was increased
up to 28 days p.i. (Figure 6). The microarray data revealed gene
expression of seven kappa (k) light chain genes, heavy chain Ig
alpha chain C (Ihg-vj558), Ighm and Ighg, indicating the
formation of IgA, IgM and IgG.
In summary, approximately 40% of the genes expressed in the
lungs could be annotated according to function. The chronology
of immunological processes comprises broad pathogen recogni-
tion, prediction of cell recruitment by cytokine and receptor
expression, MHC class I and II antigen presentation, and markers
for both antibody and cell-mediated immunity.
Cytokine profiles in mouse sera
The concentration of thirty-three cytokines was determined in
mouse sera by ELISA and multiplex immunoassay (MIA). B.
pertussis infection induced nine cytokines: CCL11, CCL20,
CXCL9, CXCL10, G-CSF, IL-1a, IL-6, IL-9 and IL-17A
(Figure 7). The pro-inflammatory cytokines, IL-1a and IL-6, are
both involved in the acute phase response. The concentration of
IL-1a was significantly increased 1 day p.i. Enhanced concentra-
Figure 1. Lung clearance of naive and reinfected mice after B. pertussis infection. (A) Number of colony forming units (cfu) in challenge
culture (C.C.) was confirmed before challenge. All other cfu were determined in lung of challenged mice (mean n=3). A large fraction of the original
infection dose was traceable in the lungs of mice 2 hours p.i. Bacteria were able to colonize and multiply approximately 100-fold at 7 days p.i. After
one week, the mice were able to clear bacteria, which resulted in cleared lungs (2 out of 3 mice) at the last time point (day 28 p.i.). (B) Reinfection was
performed at 56 days after primary infection and the number of cfu were counted after 4 hours p.i. While reinfected mice were able to clear B.
pertussis from the lungs within 2 days p.i., naive mice showed a similar pattern as observed in Figure 1A.
doi:10.1371/journal.pone.0104548.g001
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tions of IL-6 were detected at three different time points: 2 hours
(not significant), 4 days, and 7 days p.i. (Figure 7A). Remarkably,
IL-6 concentrations returned to basal level 6 hours p.i. Production
of IL-1a by epithelial cells was most likely a result of LPS or
tracheal cytotoxin (TCT) exposure [59]. The enhanced concen-
tration of IL-6 2 hours p.i. was most likely caused by lung-resident
immune cells, such as macrophages and mast cells. These cells are
the firstto recognize bacterial infection [13]. Elevated concentra-
tions of chemokines CXCL9 (MIG) and CXCL10 (IP-10) were
measured between 14–28 days p.i., which suggests a Th1 response
[60]. CCL11 (Eotaxin) was enhanced at 14 days p.i. (Figure 7E).
Eotaxin is involved in allergic inflammation and is chemoattractive
for eosinophils [61] and CCR3+ Th2 lymphocytes [62]. IL-9 was
increased 7 days p.i. (Figure 7F). IL-9 is mainly produced by T-
Figure 2. Pulmonary gene expression profiles as function of time after B. pertussis infection. Fold changes in expression were calculated
compared to naive mice and significant gene expression results (FR$1.5, p-value#0.001) are visualized as heatmap (mean of n= 3). In total, 558
genes were found to be differentially regulated, divided in 446 up-regulated genes (red) and 112 down-regulated genes (green). Genes not
exceeding a fold change of 1.5 are depicted as basal level (black) at this time point. Results are divided in 5 clusters representing up/down-regulation
and time of involvement including corresponding GO-BP terms and KEGG pathways.
doi:10.1371/journal.pone.0104548.g002
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cells and originally associated with Th2 responses [63]. However,
there is evidence that IL-9 is produced by a specific T-cell subset:
Th9 cells [64] and Th17 cells [65]. A Th17 response was identified
by markers, such as IL-17A, CCL20 (MIP-3a) and granulocyte
colony-stimulating factor (G-CSF) [34]. Enhanced concentrations
of IL-17A and CCL20 were determined in mouse sera 14 days p.i.
(Figure 7G–H). CCL20 binds exclusively to CCR6, which is
highly expressed on Th17 cells [32,33]. G-CSF was produced
between 4 and 28 days p.i. G-CSF is important for recruitment,
differentiation and proliferation of neutrophils [66] and is linked to
a Th17 response [67]. No significant changes in concentrations
were detected for the other twenty-four cytokines.
In conclusion, serum cytokine profiles indicate the induction of
an acute phase response (IL-1a and IL-6) followed by a multi-
flavored immune response with Th1 (CXCL9 and CXCL10), Th2
(CCL11 and IL-9) and Th17 signatures (G-CSF, CCL20, IL-9 and
IL-17A).
Cellular composition of the spleen
The cellular composition of the spleen was examined (Figure 8A
and Figure S2) by flowcytometry with a panel of fluorescence-
labeled monoclonal antibodies binding to cell-specific membrane
markers (Figure S3 and S4). Results indicate that in the naive
situation, the majority of splenocytes consist of B-cells and T-cells
(approximately 40% each). Upon B. pertussis infection, the ratio
between B-cells and T-cells changed, since an increased percent-
age of T-cells and decreased percentage of B-cells was observed on
day 2–4 p.i. However, this ratio was restored on day 7 p.i. The
distribution of minor cell populations in the spleen, such as DCs,
neutrophils and CD14+ cells, changed over time upon B. pertussis
infection. Here, we observed an early increased percentage of
CD14+ cells (day 1 p.i.) and DCs (day 1 and day 7–14 p.i.).
Furthermore, a gradual increased percentage of neutrophils from
day 4 until day 21 p.i. was observed. Importantly, enlargement of
the spleen was observed during the course of infection (not
quantified), suggesting influx or proliferation of cells. This might
explain the observed changes in cellular distribution.
In conclusion, cellular composition of the spleen indicates
fluctuations over time upon B. pertussis infection.
Gene expression in the spleen
Gene expression in the spleen of infected mice was determined
by microarray analysis. The study identified 798 genes of the
whole genome that were differentially regulated (p-value#0.001,
FR$1.5): 342 genes were up-regulated, 425 genes were down-
regulated, and 31 genes that were initially down-regulated and
subsequently up-regulated (Figure 8B). All involved genes are
listed in Table S2. A limited set of genes showed altered gene
expression between 4 hours and 7 days p.i. However, large
changes in gene expression were observed 21 days p.i., while the
gene expression was almost back to the original values 28 days p.i.
Only eight genes still showed altered expression. Over-represen-
tation analysis (ORA) of the 798 differentially expressed genes in
the spleen revealed 66 GO-BP terms and two KEGG pathways. A
selection of 16 terms and 2 pathways is presented in Figure 9,
which are involved in transcription, cell cycle, chromatin assembly
and a number of immunological processes. The corresponding
proteins are involved in proliferation, differentiation or activation
of immune cells in the spleen. Down-regulated genes encode
proteins that are involved in transcription, adaptive immune
responses, antigen processing, antigen presentation and chemokine
signaling (Figure 8B and 10). Down-regulation of these genes
suggests suppression of the immune response or migration of
immune cells.
Immune response. Forty-one immune response genes were
identified (Figure 10), 13 of which are associated with the adaptive
immune response. Interestingly, down-regulation of genes in-
volved in T-cell activation, B-cell activation, antigen processing
and presentation, and the subsequent BCR signaling pathway
were observed 21 days p.i. (Figure 10). Up-regulation of genes
encoding immunoglobulin heavy chains Ighg, Igha and Igh-vj558
indicate production of immunoglobulins IgG and IgA by B-cells
(Figure 10). Down-regulation of the Ighm gene suggests a
suppressed IgM production or a class-switch to IgG or IgA.
Membrane receptors. Up-regulation of genes encoding
myeloid cell membrane markers, Fc-receptors and membrane
attack complex (MAC) inhibitory proteins (Cd59a/Cd59b)
suggests increased presence of myeloid cells, such as neutrophils,
between 10 and 21 days p.i. (Figure 10). The induction of the
MAC-inhibitory genes suggests inhibition of MAC formation,
which is part of the complement cascade. In addition, BioGPS
analysis (Figure S5) revealed the presence of myeloid cell markers
that are expressed on neutrophils (Trem3 and Clec4e) or
macrophages (Clec4e). Down-regulated gene expression of mem-
brane markers of B-cells (Cd22, Cd72, Cd74 and Siglecg) and T-
cells (Sema4d, Tcra) implies decreased presence of lymphocytes 21
days p.i. (Figure 10).
Transcription. Ninety-five genes that were differentially
regulated in the spleen turned out to be involved in transcription
(Figure 9), of which 70 genes were down-regulated (data not
shown).
Figure 3. Principal component analysis of pulmonary gene
expression. An evolving gene expression profile was indicated after B.
pertussis infection of naive mice (Mean of n= 3), illustrated as principal-
component analysis (PCA). PCA is a mathematical algorithm [117],
which describes data based on (dis)similarity. Therefore, a greater
distance between points in the plot corresponds to a greater
dissimilarity. In this figure, the similarity of the 10 time points are
compared based on the expression profiles of the 558 differentially
expressed genes. Results indicate that 81% and 9% of the variance
between time points could be addressed by principal component 1
(PC1) and PC2, respectively. The next principle components contribute
for the residual variances. The plot revealed a notable change in gene
expression at 2 days p.i. compared to 4 hours p.i., and largest
differences at 14 days p.i. The gene expression at 28 days p.i. was still
far from the naive state.
doi:10.1371/journal.pone.0104548.g003
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Cell cycle. Most of the genes involved in the cell cycle process
(31 out of 45) were up-regulated (Figure 10) which suggest
increased cell replication between 10 and 21 days p.i. in the spleen.
Regulation of apoptosis. Apoptosis was characterized by
up-regulation of 12 genes (between 7 and 21 days p.i.) and down
regulation of 24 genes (21 days p.i.) (Figure 10). The role of
apoptosis is especially interesting because of the recently described
link between apoptotic markers and influenza vaccine responsive-
ness [68]. However, no overlap was found between the markers
from the study of Furman et al. and the current study.
In summary, most prominent differences in gene expression in
the spleen were found around 21 days p.i. These differences point
Figure 4. Functional annotation of pulmonary gene expression data after B. pertussis infection. Over-representation analysis (Benjamini-
corrected p-value#0.05) in GO-BP and KEGG databases of pulmonary gene expression data resulted in respectively 122 terms and 20 pathways
significantly enriched. A selection of terms and pathways, based on immunological relevance and exclusion of overlapping terms, is given in this
figure. GO-BP terms were divided in mother terms (dark blue) and corresponding daughter terms (light blue). For each term the amount of genes, the
percentage of the total term population and the Benjamini-corrected p-value are shown.
doi:10.1371/journal.pone.0104548.g004
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to down-regulation of immunological processes. After 28 days p.i.
the expression profiles returned to basal level, at the same moment
that the bacteria were almost cleared from the lungs. Interestingly,
when combining cellular composition (Figure 8A) with gene
expression profiles (Figure 8B and Figure S5), the increase in
neutrophils (10–21 days p.i.) was observed with both techniques.
However, changes in the distribution of B-cells and T-cells on day
2 and 4 p.i. were not detected on gene expression level. Overall,
these findings suggest that gene expression profiles cannot directly
be translated in cellular fluctuations in the spleen.
Overlap of transcriptomic responses in lungs and spleen
A comparison of transcriptomic datasets was made to determine
the related biological processes that occurred in both spleen and
lungs (Figure S6). Seventy-two genes were differentially expressed
in spleen and lungs, which were divided in four groups: (i) 20 genes
that were up-regulated in both tissues, (ii) 42 genes that were up-
regulated in lungs and down-regulated in the spleen, (iii) 2 genes
that were down-regulated in lungs and up-regulated in the spleen,
and (iv) 8 genes that were down-regulated in both tissues. Fifteen
genes of the second group were involved in the immune response,
such as leukocyte activation, BCR signaling pathway, antigen
processing and presentation, and chemotaxis. Remarkably, the
immunoglobulin-mediated immune response was the only process
up-regulated in both tissues, suggesting local and systemic
antibody production.
In summary, both tissues showed activation of antibody-
mediated immunity upon a B. pertussis infection. In addition,
most differentially expressed genes representing immunological
processes were observed up-regulated in the lungs and down-
regulated in the spleen.
Pertussis-specific IgM, IgG and IgA antibody responses
Antibody isotypes, IgM, IgG and IgA against B. pertussis were
analyzed for a period of 28 days p.i. The formation of IgM against
B. pertussis antigens present in outer membrane vesicles (OMV)
was not observed during the course of infection (Figure 11A).
Contrarily, anti-B. pertussis IgG in mouse sera was detectable
from 10 days p.i. and the responses were progressively increased
until 28 days p.i. (Figure 11B). Notably, no IgG titers were
detectable against the individual purified B. pertussis antigens
pertactin (Prn), pertussis toxin (Ptx), filamentous hemagglutinin
(FHA) or fimbria type 2 and 3 (Fim2/3) (Figure S7). However,
anti-OMV IgG was significantly increased at 14, 21 and 28 days
p.i. (Figure 11C) and consisted of IgG1, IgG2a and IgG2b
subclasses, but not IgG3. (Figure 11D–G), Remarkably, IgG1
levels dropped significantly at 28 days p.i. compared to 21 days p.i.
In addition, significantly increased anti-OMV IgA responses were
measured in sera (Figure 11H) as well as in lung lysates
(Figure 11I) 28 days p.i.
In conclusion, intranasal infection leads to a broad spectrum of
systemic antibody subclasses against outer membrane proteins of
B. pertussis within 14 days p.i., but responses against purified
virulent antigens Ptx, Prn, FHA and Fim2/3 remain undetectable
until 28 days p.i. Moreover, B. pertussis-specific anti-OMV IgA
antibodies were secreted in the lungs.
CD4+ T-cell responses after B. pertussis infection
Cytokine profiles of antigen-specific memory CD4+ T-cells in
the spleen were determined 66 days p.i. Splenocytes of naive and
infected mice were stimulated for 8 days with Ptx, FHA or Prn,
important virulence factors present in the acellular pertussis
vaccine. Cytokine profiling on single cell level was established by
using intracellular cytokine straining (ICS), while cytokine
concentrations in splenic culture supernatants were determined
by using a MIA. CD44 expression was used to focus on activated
CD4+ T-cells. Results of ICS indicate a significant increase in
IFNc- and IL-17A-producing Prn-, FHA-, and Ptx-specific
CD4+CD44+ T-cells after infection (Figure 12A and B). Except
for FHA-stimulation, no evidence was found for specific IL-5-
producing CD4+CD44+ T-cells (Figure 12C). Cytokine profiles in
culture supernatant revealed a significant increase in TNFa
production by splenocytes of infected mice after FHA stimulation
and IL-17A production after Prn, Ptx, or FHA stimulation
(Figure 12D–F). No changes were observed in IFNc production in
culture supernatants (Figure 12D–F). Notably, FHA stimulation
induced besides Th1 and Th17 cytokines an increase in IL-5, IL-
13, IL-4, and IL-10 production by splenocytes of infected mice
(Figure 12E). IL-5 and IL-13 production occurred also after Prn
stimulation (Figure 12D). This might indicate that these three B.
pertussis antigens induce a mixed Th-subset CD4+ T-cell response,
of which Th1 and Th17 are the major components. While ICS
specifically focuses on CD4+CD44+ T-cells, multiple cell types can
produce the accumulated cytokines present in the splenic culture
supernatants after stimulation. The production of IL-17A is
exclusive for Th17 cells [69]. Besides Th1 cells, IFNc could also be
produced by CTLs and NK-cells. The high levels of IFNc
produced by splenocytes of naive mice after Ptx stimulation may
be explained by TLR4 activation on innate cells by Ptx [70]. A
high background of Prn-responding IL-17A+CD4+CD44+ T-cells
and IL-17A in supernatant was seen in two out of six naive mice,
indicating Prn-activated IL-17A production in unprimed spleno-
cytes.
In summary, CD4+ memory T-cell analysis revealed that
infection with B. pertussis primarily generates specific Th1 and
Th17 responses, regarded essential in protection against a B.
pertussis infection [12,20,21].
Discussion
An integrated systems biology approach was applied to
investigate the evolving immune response of mice following a
primary intranasal B. pertussis infection, considered capable of
inducing sterilizing immunity. Data sets from individual analytical
platforms, such as microarray, flow cytometry, multiplex immu-
noassays, and colony counting, addressing different biological
samples taken at multiple time points during the immune response
were merged. Altogether, a comprehensive overview of immuno-
logical processes occurring upon primary infection of mice with B.
pertussis was constructed in three consecutive phases, as shown in
Figure 13: (i) the innate phase, (ii) the bridging phase, and (iii) the
adaptive phase.
Highlights featured in this study are: (i) a protracted acute phase
response, as part of the innate phase, lasting for at least 28 days,
which co-occurred with prolonged antigen exposure; (ii) the
recognition of several B. pertussis ‘PAMPs’ (pathogen associated
Figure 5. Gene expression profiles of pulmonary cytokines and membrane receptors after B. pertussis infection. Results for cytokines
and membrane receptors include expected source and known corresponding receptors, target cells and receptor ligands. Membrane receptors are
divided in eight different groups according to function. (Mean of n = 3).
doi:10.1371/journal.pone.0104548.g005
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Figure 6. Pulmonary gene expression representing immunological pathways as function of time after B. pertussis infection. Details on
pulmonary gene expression profiles indicated expression of anti-microbial peptides, acute phase proteins, pathogen recognition, phagocytosis, both
classical and alternative pathways of complement cascade, transcription factors, antigen presentation via both MHC-I and MHC-II, B-cell receptor
(BCR) signaling and immunoglobulin related genes. (Mean of n = 3).
doi:10.1371/journal.pone.0104548.g006
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molecular pattern), i.e. LPS, DNA and GalNac, (iii) early
signatures for recruitment of adaptive immune cells e.g. the
cytokine CCL20 that attracts CCR6+Th17 cells, (iv) expression of
specific membrane markers (e.g. DAP12) and transcription factors
that determine the strength and direction of the adaptive immune
response. Furthermore, features of adaptive immunity consisted of:
(v) IgA secretion in the lungs; (vi) a broad systemic antibody
response; (vii) a Th1 and Th17-mediated response in the lungs and
(viii) systemic formation of specific memory Th1 and Th17 cells.
Various signatures, associated with the induced protective
immune response as presented in Figure 13, are discussed in
detail hereafter. The innate phase was characterized by the
presence of AMPs, acute phase proteins and chemotactic cytokines
as detected by microarray analysis and MIA (Figure 5–7).
Expression of the involved genes is most likely initiated by
activation of TLR2 and TLR4 by LPS of B. pertussis [8,10]. Up-
regulated gene expression of four AMPs (Chi3l1, Cxcl17, Lcn2,
Spli) was found in the lungs during the whole course of infection.
These AMPs contribute to innate protection as was shown for
other respiratory pathogens [38–40,42]. In addition, these AMPs
have the capacity to recruit immune cells, such as neutrophils,
DCs, and monocytes [37,41] and are therefore important for the
induction of subsequent immune responses [36].
Figure 7. Serum cytokine concentrations as function of time after B. pertussis infection. The concentrations of (A) IL-1a, (B) IL-6, (C) CCL11,
(D) CXCL9, (E) IL-17A, (F) IL-9, (G) CXCL10, (H) CCL20, and (I) G-CSF in serum were analyzed over time. Results indicated that after the acute phase
response (IL-1a and IL-6) a multi-flavored immune response with Th1 (CXCL9 and CXCL10), Th2 (CCL11 and IL-9) and Th17 (G-CSF, CCL20, IL-9 and IL-
17A) was induced. Data represented as mean concentrations including individual values (n = 3). p-values were determined by one-way ANOVA with
multiple comparison compared to naive mice (* = p,0.05, ** = p,0.01, *** = p,0.001 and **** = p,0.0001).
doi:10.1371/journal.pone.0104548.g007
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Furthermore, the expression of particular cytokines on gene and
protein level in the innate phase (Figure 5 and 7), in combination
with increased gene expression of cytokine receptors and the
change in cellular composition of the spleen (Figure 5 and 8A),
gave detailed insight into the immunological processes during the
course of infection, as depicted in Figure 13. For example, the
gene expression levels of the cytokines Cxcl1, Cxcl2, Cxcl5 and
Cxcl17 was in agreement with the recruitment of neutrophils and
DCs towards the site of infection [41,71,72]. Furthermore, the
gene expression of the cytokines Cxcl9, Cxcl10, Cxcl11 and Ccl20
was increased early after infection. CXCL9, CXCL10 and
CXCL11 are known to be involved in the recruitment of
CXCR3+ Th1 cells, and CCL20 in the recruitment of CCR6+
Th17 cells [32,33,60]. The up-regulation of Ccr6 and Cxcr3 genes
was observed at day 14 p.i. in the lung (Figure 13).
Remarkably, gene expression of cytokines, acute phase proteins
and AMPs was temporary suppressed at 2 days p.i. Simultaneous-
ly, the proliferation of bacteria started in the lungs. These results
indicate temporary suppression of the immune system by B.
pertussis. Several immune evasion strategies of B. pertussis have
been described in literature [73–77]. The evasion is attributed to
virulence factors, such as adenylate cyclase toxin (ACT), pertussis
toxin (Ptx), tracheal cytotoxin (TCT) and filamentous hemagglu-
tinin (FHA). These investigators demonstrated enhanced produc-
tion of IL-10 and regulatory T-cells, delay of neutrophil
recruitment, and inhibition of early chemokine production in
mice in relation to secretion of B. pertussis virulence factors. In the
present study, these immunosuppressive properties of B. pertussis
might explain the suppression of the differential gene expression
observed 2 days p.i. In addition, secretion of OMVs occurs during
Figure 8. Splenic cellular composition and gene expression profiles as function of time after B. pertussis infection. (A) The distribution
of the splenic cellular composition illustrated as pie charts at a selection of time points during the B. pertussis infection. FACS was used to determine
the percentage (mean of n = 3) of B-cells (CD19+), CD4+ T-cells, CD8+ T-cells, neutrophils (Gr-1+), macrophages (CD11b+), dendritic cells (33D1+), NK-
cells (DX5+) and CD14+ cells (CD14+) in splenocytes. (B) Fold changes of expression were calculated compared to naive mice and significant gene
expression results (FR$1.5, P-value#0.001) were visualized as a heatmap (Mean of n = 3). This test was performed for each gene at each time point. In
total, 798 genes were differentially regulated (FR$1.5, p-value#0.001) compared to naive mice, divided in 342 up-regulated (red) and 425 down-
regulated genes (green). Additionally, a distinct group of 31 genes showed down-regulation between 4 hours and 4 days p.i., but were up-regulated
between 10 and 21 days p.i. Genes not exceeding a fold change of 1.5 are depicted as basal level (black) at this time point. Results are divided in 3
clusters representing up/down-regulation and time of involvement and included corresponding GO-BP terms and KEGG pathways.
doi:10.1371/journal.pone.0104548.g008
Figure 9. Functional annotation of splenic gene expression data after B. pertussis infection. Over-representation analysis (Benjamini-
corrected p-value#0.05) of all 798 differentially expressed genes in the spleen in GO-BP and KEGG databases, This resulted in respectively 66 terms
and 2 pathways significantly enriched of which a selection, based on immunological relevance and exclusion of overlapping terms, of 16 terms and 2
pathways are presented. GO-BP terms were divided in mother terms (dark blue) and corresponding daughter terms (light blue). For each term the
amount of genes, the percentage of the total term population and the Benjamini-corrected p-value are shown.
doi:10.1371/journal.pone.0104548.g009
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bacterial colonization [78]. These OMVs are thought to serve as
decoy for the host immune response and their immunomodulatory
properties support survival of the bacteria [79,80].
During the bridging phase, the number of bacteria in the lungs
increased (Figure 1). The highest number of bacteria in the lungs
was found at 7 days p.i. followed by a decrease, suggesting that day
7 is the turning point in the progress of the infection.
Simultaneously, microarray analysis suggests the presence of
neutrophils, macrophages, and DCs in the lungs based on BioGPS
analysis (Figure S1). These cells are likely responsible for (i)
phagocytosis, (ii) pathogen recognition, (iii) antigen presentation
and (iv) differentiation by expression of cell receptors in the period
between 4–10 days p.i. (Figure 13).
The innate immune cells appeared to cause the initial decrease
in numbers of bacteria in the lungs from 7 days p.i., because a
strong antibody response (IgM, IgG, IgA) (Figure 11) and CD4+
cell response were not yet present. Based on gene expression of
neutrophil markers, the neutrophil invasion in the lungs probably
occurred from 4 days p.i., which is observed on cellular level by
McGuirk et al. [81]. This influx of cells is most likely orchestrated
by IL-17A and G-CSF [66,67,69]. In the present study, both
cytokines were enhanced in the sera of infected mice. Further-
Figure 10. Splenic gene expression profiles of specific processes as function of time after B. pertussis infection. Expression profiles are
summarized for immune response, cell cycle, regulation of apoptosis, T-cell activation, B-cell activation, immunoglobulin, B-cell receptor (BCR)
signaling, antigen processing, cytokines and membrane receptors in spleen. (Mean of n = 3).
doi:10.1371/journal.pone.0104548.g010
Figure 11. Antibody profiling after B. pertussis infection. Antibody responses were determined in mouse sera after intranasal infection by
whole cell B. pertussis ELISA or MIA and expressed as OD450 or Fluorescent Intensity (F.I.) respectively. (A) IgM against OMV B1917 were absent. (B)
Whole cell B. pertussis ELISA indicated IgG antibody formation 10–14 days p.i., which increased until day 28 days p.i. (C–G) Levels of total IgG and
individual subtypes (IgG1, IgG2a, IgG2b and IgG3) against OMV B1917 indicated presence of multiple subclasses. (H) Anti-OMV IgA antibodies in
serum were induced after 14–28 days p.i. (I) In lung lysates, anti-OMV IgA antibodies were detected 14 and 28 days p.i. I p-values were determined by
one-way ANOVA with multiple comparison compared to naive mice (* = p,0.05, ** = p,0.01, *** = p,0.001 and **** = p,0.0001). (Mean of n = 3).
doi:10.1371/journal.pone.0104548.g011
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more, genes involved in phagocytosis were found to be up-
regulated (Figure 6) which is important for protection against B.
pertussis [55,82].
This study demonstrated also that B. pertussis infection activates
different pattern recognition receptor (PRR) pathways, such as
TLR4, TLR9, DAI and several CLRs (Figure 6). Bacterial ligands,
e.g. LPS, DNA and GalNAc trigger these signaling pathways
[8,45,47]. Up-regulation of genes involved in TLR4-signalling
(Md-1, Irf5) is probably caused by detection of bacterial LPS
[8,10,43]. Bacterial DNA recognition occurred through the TLR9
pathway (Ctsk, Irf7) and the cytosolic DNA sensor (Dai). The
receptor DAI recognizes both host DNA, upon tissue damage, and
bacterial DNA, which leads to an innate immune response [45].
Furthermore, increased gene expression of the CLRs, Signr7,
Signr8 and Mgl1 was observed, which are predominantly
expressed on DCs [28,83]. The enhanced expression of mouse
DC-SIGN-related genes Signr7 and Signr8 during the B. pertussis
infection is a novel finding. Despite indications of sensing of 6-
sulfo-sialyl Lewis(x) oligosaccharide by Signr7, the exact ligands
and role of these receptors remains to be discovered [46].
Recognition of GalNAc via Mgl1 has recently been associated
with mast cell activation by B. pertussis [47]. An important
conclusion is that ligands of B. pertussis activate multiple pathogen
recognition pathways during the infection. This may be important
for the induction of a broad adaptive immune response, including
Th1 as well as Th17 cells, mucosal IgA and systemic IgG.
During the bridging phase, up-regulation of MHC class I and II
genes were measured, enabling antigen presentation to both CD4+
Th-cells and cytotoxic CD8+ T-cells (CTLs). Several studies
focused on the role of Th-cells because of their important
contribution to protect against B. pertussis [12,20,21]. Neverthe-
less, the CTLs seem also important for protection against B.
pertussis, indicated by CTL infiltration in lungs and formation of
FHA-specific IFNa˜-producing CTLs upon B. pertussis infection as
was previously found in mice and humans [81,84].
In addition, the bridging phase was characterized by simulta-
neous gene expression of several receptors on innate immune cells
in the lungs and spleen. Interestingly, this included MAIRs,
TREMs, semaphorins and DAP12, which is the first evidence that
these receptors might play a role in B. pertussis infection.
Especially DAP12, which is abundantly expressed in lungs,
interacts with other membrane receptors and influences cytokine
expression [85]. Coupled to MAIR-II, DAP12 is an inhibitor of B-
cell responses [86]. Together with TREM2, DAP12 down-
regulates TLR and FcR expression [87]. Overall, these former
receptors function as an important bridge between innate and
adaptive immune responses, determining the strength and
direction of the adaptive immune response by the successive
activation of lymphocytes, such as CTLs, Th-cells, and B-cells
[29,88–91]. Since the exact role of these receptors in the
protection against B. pertussis remains unresolved, additional
research is needed to find whether targeting of these receptors
might be a viable strategy to elicit desired immune responses. In
summary, the bridging phase suggests the presence of APCs and
myeloid cells, such as DCs and neutrophils based on gene
expression of membrane markers. However, this was not validated
by histological data.
Finally, the adaptive phase was recognized by the formation of
T-cell and B-cell responses and a broad humoral response
(Figure 13). In this same period, the naive mice were able to
clear B. pertussis from their lungs. Gene expression, cytokine
secretion and cellular analysis revealed presence of activated CD4+
Th-cells. The highest number of CD4+ Th-cells was detected at 14
days p.i., which is in agreement with a study showing the largest
influx of Th17 cells in the lungs after B. pertussis infection at 14
days p.i. [12]. Phenotyping of CD4+ Th-cells, based on cytokine
profiles in serum (protein) and lung (genes) and expression of
specific transcription factors or membrane markers, suggests a
broad Th-response in the present study. The Th1 response in the
lungs was characterized by Ifng and Stat1 expression [92]. Gene
expression of the mucosal homing receptor Ccr6, Card11, Ccl19,
Ccl21a, Ccl21c, and signature cytokines Il17a and Il17f might
indicate Th17 cells in the lungs [32,69,93–96]. Upon re-
stimulation of splenocytes with purified B. pertussis antigens,
Prn- and FHA-specific Th1 and Th17 type CD4+ T-cells could be
detected in the memory phase (66 days p.i.) (Figure 12). In
addition, enhanced IL-9 levels in serum suggest activation of Th9
cells and Th17 cells as these cells produce large amounts of IL-9
[64,65]. However, Tregs, NKT-cells and mast cells are also
sources of IL-9. In summary, the different phases of T-cell
development were mapped; the expansion phase of naive T-cells
in the spleen (2 days p.i.), the effector phase in the lungs (14 days
p.i.), contraction phase in the spleen (21 days p.i.) and finally the
specific memory T-cells (66 days p.i.) (Figure 5, 8A, 10 and 12).
Data from this study suggests generation of local specific Th1/
Th17 cells in the lungs. Th1 cells, which produce IFNc are
important for clearance of B. pertussis. Postponed clearance was
shown in IFNa˜-depleted mice [97]. Th17 cells have been indicated
as key cells to control bacterial infections at mucosal sites [98].
Recent studies revealed that Th17 cells increase the clearance of
B. pertussis after an intranasal infection in animals [12,13,99].
Infection with B. pertussis induces also B-cell and antibody
mediated immunity. Microarray analysis showed increased gene
expression of the BCR in the lungs. In addition, gene expression of
IgM, IgG and IgA was observed in lungs and spleen. Whereas,
most genes for antibody isotypes were found up-regulated in both
tissues, IgM was down-regulated in the spleen (Figure 6 and 10).
This was confirmed by the detection of IgA and IgG (IgG1, IgG2a
and IgG2b) after 14 days p.i. However, IgM antibodies were not
found systemically (Figure 11). In mice, IgG1 is associated with a
Th2-like response, while IgG2a (in Balb/c mice) and IgG2b
suggest induction of a Th1 response [100]. IgG2b is also linked to
Th17 lymphocytes [101]. All antibody responses in the present
study were directed against whole cell B. pertussis and outer
membrane vesicles, but not against the B. pertussis antigens that
are typically present in acellular vaccines: Ptx, Prn, FHA and
Fim2/3. However, memory Th1/Th17 cells were detected upon
re-stimulation with Prn and FHA (Figure 12). The polymeric
immunoglobulin receptor (pIgR) was highly expressed during the
whole course of B. pertussis infection in the lungs. pIgR is essential
for the transport of IgA into the mucus and is seen as a bridge
between innate and adaptive mucosal responses [102,103]. The
expression of pIgR was drastically enhanced 14 days p.i., leading
to secretion of mucosal IgA in the lungs (Figure 5 and 11).
Interestingly, the increased pIgR expression coincided with IL-
17A production in the lungs and sera (Figure 5 and 7), which is in
agreement with the finding that Th17-mediated responses
influence the local humoral response by inducing pIgR expression
and elevating secretory IgA levels [104]. Therefore, the transport
of IgA to the mucosa, which is orchestrated by IL-17A via the
induction of pIgR, supports an important role for local immunity.
In summary, B. pertussis infection induces a broad humoral
response, which was observed by gene and protein expression.
Our study also contains several conceptual points for discussion.
First, altered gene expression in the spleen caused by B. pertussis
infection was modest, except for 21 days p.i. Two possible reasons
can be given: (i) the infection initiated a local immune response in
the lungs and (ii) gene expression is required to be rather strong to
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exceed the significance threshold. After the lungs and the draining
lymph nodes, the spleen is the third organ in line involved in the
generation of the immune response. Therefore, gene expression
effects could be less abundant. Furthermore, the spleen consists of
many cell types with different gene expression profiles, so changes
in expression levels in a single cell type might not have been
detected. Cell sorting of individual cell types and subsequent gene
expression profiling could overcome this problem. Second, specific
antibody and T-cell responses were only measured for a limited set
of available purified antigens. The inclusion of other antigens, such
as outer membrane proteins, would perhaps have allowed a more
detailed analysis. Third, in this study we propose murine infection-
induced immune signatures as a benchmark to be used in the
development of improved human pertussis vaccines. Since B.
pertussis is not a natural pathogen for mice, translation of the
results obtained in this study to the human situation remains to be
interpreted with caution. Nevertheless, using a (naive) murine
model has several advantages. It is regarded an important small
Figure 12. Systemic memory Th-cytokine profiles. (A–C) Splenocytes of naive and infected mice were collected 66 days p.i. and in vitro
restimulated with Prn, FHA or Ptx for 8 days. The percentages of IFNc-, IL-17A-, and IL-5-producing CD3+CD4+CD44+ T-cells were determined using
ICS. (D–F) Cytokine levels in supernatant after 7 days of stimulation were determined by using a MIA. Results (mean of n = 6) are corrected for the
background level in the presence of medium as control. Statistical differences between the groups were detected for the ICS with a non-parametric
Mann-Whitney test and for the MIA with a Student t-test on the log-transformed data. ** = p,0.01, *** = p,0.001, **** = p,0.0001.
doi:10.1371/journal.pone.0104548.g012
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animal model for pertussis vaccine development [105] and enables
to dissect the local and systemic immune response in great detail,
as shown in this study, rather than using blood or nasal washes
from humans undergoing a B. pertussis infection. Furthermore,
the role of individual gene signatures and products could be
assessed in future research in mice by using knockin or knockout
strains, or by functional interventions. Encouraging is that many
observations made in this study, such as the rapid clearance upon
reinfection and involvement of Th17 and Th1 responses, are in
line with recent studies on B. pertussis infection in baboons, which
resemble the human situation more closely [13,15]. Translation of
biomarkers from mouse to man however should be performed
with care.
Overall, our study describes the molecular and cellular sequence
of events that eventually lead to the induction of protective
immunity to pertussis, including local immunity in the lungs,
which is not induced by current vaccines. Especially the inductions
of Th1 and Th17 cells and IgA in the lungs are regarded key
elements in superior immunity. Our data can be used to select
vaccine concepts that resemble infection, with respect to e.g.
administration route and prolonged antigen exposure, and
immune signatures elicited. Local delivery of vaccines may be an
important advancement for improved protection as was previously
demonstrated with a live attenuated pertussis vaccine [106]. Also
adjuvants could be selected and optimized that can steer host
immunity of inactivated vaccines towards an infection-like
immune response with minimal adverse effects. The molecular
and cellular fingerprint of the local immune response discovered in
B. pertussis infected mice thus can provide a strong guidance for
developing improved pertussis vaccines.
Methods
Ethics Statement
The independent ethical committee for animal experimenta-
tions ‘Dierexperiment Commissie (DEC)’ of the National Institute
for Public Health and the Environment (RIVM) reviewed the
animal experiments in this study according to the guidelines
provided by the Dutch Animal Protection Act. The committee
approved documents with the identification numbers
‘DPA201100230’ and ‘DPA201100348’.
Figure 13. Overview of immune response evolving after B. pertussis infection.Merging data from a wide array of functional analyses reveals
a comprehensive overview of the immune response of mice upon B. pertussis infection. (i) Innate phase, (ii) bridging phase and (iii) adaptive phase are
indicated in the response facing variable levels of B. pertussis present in the initial inoculum, the exponential growth phase, and in the clearance
phase, respectively. Highlights of the study are given, based on lung clearance, relative gene expression levels (lungs), cytokine profiles (serum),
cellular response (spleen) and pertussis-specific responses in serum and spleen as depicted in the figure legend.
doi:10.1371/journal.pone.0104548.g013
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Materials
Bordetella pertussis strain B1917 [107] was isolated in The
Netherlands in 2000 and was kindly provided by Frits Mooi.
Bordet Gengou agar plates with 15% sheep blood were purchased
from BD (Cat. No. 254400, BD, The Netherlands). Verweij
medium was obtained from Bilthoven Biologicals (BBio, Bilthoven,
The Netherlands). PBS (pH 7.2) and Roswell Park Memorial
Institute Media 1640 (RPMI) were purchased from Invitrogen
(Gibco, Invitrogen). All RPMI media used in this experiment were
supplemented with 10% fetal calf serum (FCS, Hyclone, New
Zealand), 100 units penicillin, 100 units streptomycin, and
2.92 mg/ml L-glutamine (p/s/g; Invitrogen). Shockbuffer for
splenocyte isolation consisted of 8.3 g/L NH4CL, 1 g/L NaHCO3
and 5000 IE/L Heparine dissolved in dH2O (pH 7.4; ice cold) and
was filtered (0.22 mm) before use. FACS buffer consisted of PBS
pH 7.2 supplemented with 0.5% BSA (A3803, Sigma Aldrich,
Germany) and 0.5 mM EDTA (ICN Biomedicals). Horseradish
peroxidase (HRP) labelled goat-anti-mouse IgG and R-Phycoer-
ythrin (RPE)-conjugated goat-anti-mouse IgM, IgA, IgG, IgG1,
IgG2a, IgG2b and IgG3 were obtained from Southern Biotech
(Southern Biotech, United States) Fluorescently labeled antibodies
for flow cytometry, anti-CD3-Pacific blue (17A2), anti-CD4-
Pacific blue (GK1.5), anti-IA-IE-PerCP-Cy5.5 (M5/114.15.2),
anti-33D1-APC (33D1) and anti-IL-5-APC were purchased from
Biolegend (ITK, The Netherlands). Fluorescently labeled antibod-
ies, anti-CD4-APC (RM4-5), anti-CD8a-PerCP (53 6.7), anti-
CD69-FITC (H1.2 F3), anti-Gr-1-PE (RB6-8C5), anti-CD19-
FITC (1D3), anti-CD14-PE (rmC5-3), anti-DX5-APC (DX5),
anti-CD11b-PE (M1/70), anti-CD40-FITC (HM40-3), anti-
CD44-FITC (IM7) and anti-IFNc-PE were purchased from BD
(BD Biosciences, The Netherlands). Fluorescently labeled anti-
bodies, CD11c – PE-Cy7 (N418) and anti-IL-17a-PerCP-Cy5.5
were obtained from eBioscience (eBioscience, Austria). Live/dead
staining was purchased from Invitrogen (LIVE/DEAD Fixable
Aqua Dead Cell Stain Kit; Invitrogen). Anti-CD16/CD32 was
purchased from BD (BD, The Netherlands).
Cultivation of Bordetella pertussis
Bordetella pertussis strain B1917 was grown on Bordet-Gengou
agar plates for 4 days at 35uC. Subsequently, multiple colonies
were transferred onto new plates and grown for 24 hours at 35uC,
which was repeated 3 times. Colonies on each plate were
harvested in 1.5 ml Verweij medium [108] and the suspensions
were pooled. After centrifugation (30 min., 1932 g), cells were
washed with 15 ml Verweij medium. Subsequently, bacterial
suspensions of approximately 261010 cfu/ml were resuspended in
Verweij medium containing 15% glycerol (v/v) and aliquots of
0.25 ml were flash frozen in ethanol and dry ice and stored at 2
80uC.
Challenge culture
A stock of B. pertussis B1917 was diluted with Verweij medium
to a final concentration of 56106 cfu/ml. The number of cfu was
confirmed by plating 100 mL of the infection suspension (1:2000 in
Verweij medium) on Bordet-Gengou agar plates. Plates were
incubated for 4 days at 35uC and cfu were counted by using a
colony counter (ProtoCOL, Synbiosis, Cambridge, United King-
dom).
Animal experiment
Female BALB/c mice (Harlan, The Netherlands), 8-weeks-old,
were divided in groups of three animals and housed in cages
(macrolon III including filter top). Three healthy mice were
euthanized at day 0 and considered as naive group. Other mice
were intranasally infected under anesthesia (isoflurane/oxygen),
with 26105 cfu B. pertussis B1917 in 40 ml Verweij medium at day
0. Groups of animals (n = 3) were euthanized after 2, 4, 6 hours,
and after 1, 2, 4, 7, 10, 14, 21 and 28 days of infection,
respectively. At 56 days p.i. five groups of primary infected animals
and five groups of naive animals (n = 3) were infected as previously
described and euthanized after 4 hours, and after 2, 7, 10 and 14
days of infection. In addition, six infected and six healthy mice
were euthanized at day 21 and day 66 for the analysis of CD4+ T-
cell responses. Mice were bled, under anesthesia (isoflurane/
oxygen), by orbital bleeding and sacrificed by cervical dislocation.
Whole blood from each mouse was collected in a blood
collection tube (MiniCollect 0.8 ml Z Serum Sep GOLD, Greiner
Bio-One, Austria). After coagulation (10 min. at room tempera-
ture), sera were taken after centrifugation (10 min., 3000 g) and
stored at 280uC. Lung lobes were excised. The right lobe was
placed in 900 ml Verweij medium and kept at room temperature.
The left lobe was placed in 1 ml RNAlater (Qiagen), incubated
overnight at 4uC and stored at 280uC. The spleen was excised
and divided in two equal parts. One piece was placed in 5 ml of
RPMI medium and kept on ice. The other piece was placed in
1 ml RNAlater (Qiagen), incubated overnight at 4uC and stored at
280uC. For the analysis of CD4+ T-cell responses, whole spleen
was collected and placed in 5 ml of RPMI medium and kept on
ice.
Colonization assay
Lung tissue in 900 ml Verweij medium was homogenized for
15 seconds using a Labgen 7 Homogenizer (Cole Palmer,
Schiedam, The Netherlands). Homogenizer was sanitized between
samples with ethanol (80%) and water. Lung homogenates were
serially diluted (undiluted, 1:10, 1:100 or 1:1000) in Verweij
medium depending on the expected number of cfu. Suspensions of
100 ml were plated on Bordet-Gengou agar plates and incubated
for 4 days at 35uC. The numbers of colonies were counted by
using a colony counter (ProtoCOL, Synbiosis, Cambridge, United
Kingdom) and calculated as cfu per mouse.
RNA isolation
Lung and spleen tissue was homogenized by using a Labgen 7
Homogenizer (Cole Palmer, Schiedam, The Netherlands) in 700
and 2100 ml Qiazol (Qiagen Benelux, Venlo, The Netherlands),
respectively. RNA isolation was performed using a miRNeasy
Mini Kit with DNAse treatment (Qiagen Benelux, Venlo, The
Netherlands) according to the manufacturer’s protocol. RNA
concentrations were determined by UV spectroscopy (Tech3
module, Synergy Mx, BioTek, Winooski, United States). RNA
quality was determined by using electrophoresis (RNA nano 6000
kit, 2100 Bioanalyzer, Agilent Technologies, Amstelveen, The
Netherlands). Results were given as RNA integrity numbers (RIN)
between 1 nd 10 (manual Bioanalyzer). Samples with a RIN of 7
or higher were used for microarray analysis. For microarray
analysis of lung tissue, RNA concentrates of individual mice were
analyzed for the following time points: naive, 4 hours, 2 days, 4
days, 7 days, 10 days, 14 days, 21 days and 28 days post infection
(p.i.). For spleen tissue, samples of individual mice were analyzed
for the following time points: naive, 4 hours, 1 day, 2 days, 4 days,
7 days, 10 days, 14 days, 21 days and 28 days p.i.
Microarray analysis
Amplification, labeling and hybridization of RNA samples to
microarray chips was carried out at the Microarray Department of
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the University of Amsterdam, The Netherlands, as described
previously [109].
Briefly, 500 ng total RNA of each sample was amplified (aRNA)
according to the Agilent QuickAmp kit manual (Agilent technol-
ogies). A common reference sample for either lung or spleen tissue
was made by pooling equimolar amounts of aRNA from
individual samples of the respective tissues. Cy3 and Cy5 mono-
reactive dyes (GE Healthcare) were used to label individual
samples and the common reference sample, respectively. Labeling
was performed with 10 ml of CyDye solution and incubated for
1 hour before the reaction was quenched by adding 5 ml 4 M
hydroxylamine (Sigma-Aldrich). Purification was performed by
using a clean-up kit (E.Z.N.A. MicroElute RNA Clean Up Kit,
Omega Bio-Tek, Norcross, United States). The yields of amplified
RNA and incorporation of CyDye were determined by using a
spectrophotometer (NanoDrop ND-1000, NanoDrop products,
Wilmington, United States).
Hybridization mixture was prepared by adding a dried mixture
(1:1) of sample (Cy3) and common reference (Cy5) together with
sample tracking control (STC, Roche NimbleGen) and hybrid-
ization cocktail (NimbleGen Arrays User’s Guide –Gene Expres-
sion Arrays Version 5.0, Roche NimbleGen). Samples were
incubated successively for 5 min. at 95uC and 5 min. at 42uC.
Hybridization was performed by loading a sample onto a
microarray (NimbleGen 126135 k Mus musculus, Roche, Ger-
many) containing probes for 44,170 genes with 3 spots per target
probe. Hybridization was performed with a NimbleGen Hybrid-
ization System 4 (Roche NimbleGen) for 20 hours at 42uC. After
washing (NimbleGen Arrays User’s Guide – Gene Expression
Arrays Version 5.0), slides were scanned in an ozone-free room
with a microarray scanner (Agilent DNA microarray scanner
G2565CA, Agilent Technologies). Each microarray corresponded
to labeled RNA from specific tissue (lung or spleen) from one
individual mouse. Feature extraction was performed with Nim-
bleScan v2.5 (Roche NimbleGen) resulting in a table containing
individual probe signal intensities for both dyes. Complete raw and
normalized microarray data and their MIAME compliant
metadata from this publication have been submitted to the
GEO database (www.ncbi.nlm.nih.gov/geo) and assigned the
identifier GSE53294.
Data analysis of gene expression
Quality control was performed on raw data by means of Cy3-
Cy5 scatter plots, and by comparing signal average and
distribution across slides. All slides passed quality control. Raw
microarray data for gene-coding probes were normalized in R
(www.r-project.org), by using a four step approach [109]: (1)
natural log-transformation, (2) quantile normalization of all scans,
(3) correcting the sample spot signal for the corresponding
reference spot signal and (4) averaging data from replicate probe
spots. Further analysis of normalized data of 44170 probes was
performed in R and Microsoft Excel.
Genes differentially expressed between experimental groups
(naive and various time points p.i.) were identified by using
ANOVA. Fold ratio induction or repression of individual genes
was calculated by comparing mean gene expression levels of
infected groups to the group with naive mice. Data are presented
as the average normalized gene expression levels of three mice per
group. Probes were considered differentially expressed if they met
the following two criteria: (i) a p-value,0.001 (ANOVA), which
corresponds to a Benjamini-Hochberg False discovery rate (FDR)
[110] of ,5%; and (ii) an absolute fold ratio .1.5 (infected
compared to naive mice) for at least one time point. If multiple
probes corresponding to the same gene were significant, their data
were averaged to remove redundancy for further analysis. Gene
expression of each group was compared with the group of naive
mice. Differences in gene expression were visualized in heat maps,
(GeneMaths XT, Applied Maths, St-Martens-Latem, Belgium).
Genes were arranged according to similar expression patterns in
time at which genes exceeded the fold ratio cut-off of 1.5. To
facilitate visual interpretation of heat maps, only induction (red)
and repression (green) of gene expression levels with fold ratios .
1.5 are visualized, therefore presenting fold ratios ,1.5 as naive
level (black).
Functional enrichment with an over-representation analysis
(ORA) was carried out by using DAVID [111] based on Gene
Ontology Biological Processes (GO-BP) and Kyoto Encyclopedia
of Genes and Genomes (KEGG). Cell-specific or tissue-specific
gene sets were obtained by using data from BioGPS [112,113]. For
each cell type or tissue, gene expression data were compared to the
average of all tissues included in the data set. The top 100 genes,
which had the highest tissue-specific expression and were included
on the NimbleGen array, were selected. If the BioGPS dataset
included multiple entries for the same cell type (e.g., CD4+ and
CD8+ T-cells), the resulting sets were combined in our subsequent
analysis.
Whole cell B. pertussis ELISA
Immunoglobulin G responses against B. pertussis were deter-
mined in sera by an ELISA. Therefore, B. pertussis B1917 was
heat-inactivated for 45 min. at 56uC, after which ELISA plates
(Immunolon 2HB, Thermo Scientific) were coated overnight at
room temperature with 100 ml/well whole cell B. pertussis
(OD590 nm = 0.1 in PBS). Plates were washed with 0.03% (v/v)
Tween 80 in water. Then, plates were incubated for 1 hour at
37uC with 100 ml/well serial dilutions of serum samples in PBS,
pH 7.2 (Gibco) with 0.1% (v/v) Tween 80. Plates were washed
twice and incubated (1 hour, 37uC) with 100 ml/well of Goat anti
Mouse IgG-HRP (1:5000) in PBS with 0.1% (v/v) Tween 80 and
0.5% (w/v) Protifar (Nutricia). After washing twice, 100 ml/well
peroxidase substrate (4.2 mM Tetra Methyl Benzidine and
0.012% H2O2 in 0.11 M sodium acetate buffer, pH 5.5.) was
added, plates were incubated at room temperature and the
reaction terminated after 10 min. by adding 100 ml/well, 2 M
H2SO4 (BBio, Bilthoven, The Netherlands). Finally, the absor-
bance was recorded at 450 nm with a plate reader (BioTek reader
EL808, Bio-Tek, USA) and antibodies against whole cell B.
pertussis are presented in OD450 signal, because a reference is not
available.
Multiplex immunoassay (MIA) for antibody response
Responses of IgM, IgA, total IgG and the IgG subclasses (IgG1,
IgG2a, IgG2b and IgG3) against B. pertussis antigens P.69
pertactin (P.69 Prn), filamentous hemagglutinin (FHA), pertussis
toxin (Ptx), combined fimbria type 2 and 3 antigens (Fim2/3) and
outer membrane vesicles B1917 (OMV B1917) were determined
in sera by using a MIA. Outer membrane vesicles from B. pertussis
B1917 were produced as previously described [114] with
additional changes. Conjugation of antigens and OMVs to beads
was performed as described previously [115]. Serum was diluted
1/100 in PBS containing 0.1% Tween 20 and 3% bovine serum
albumin and mixed 1:1 with conjugated beads. After incubation
with R-Phycoerythrin (RPE)-conjugated anti-mouse IgM (1:100),
IgA (1:100), IgG (1:200), IgG1 (1:200), IgG2a (1:40), IgG2b (1:200)
and IgG3 (1:200), samples were analyzed by using a Bio-Plex
system (Bio-Plex 200, BioRad). Total IgG titers (U/ml) against B.
pertussis antigens were calculated from mean fluorescent intensity
(MFI) by using a reference from the National Institute for
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Biological Standards and Control (Code 99/520, NIBSC,
England) in the Bio-Plex Manager software (Bio-Rad Laborato-
ries). Results for IgM, IgG, IgG subclasses and IgA antibodies
against OMV B1917 are presented in fluorescent intensity (F.I.),
because a reference is not available.
Lung lysate preparation and IgA antibody assay
The lung lysates used for the colonization assay were
centrifuged (2000 g, 10 min.) and filtered (0.22 mm Millex-GV,
Merck KGaA, Darmstadt, Germany) to remove cell debris and
bacteria. Filtrates were stored at 280uC. Prior to analysis, lung
lysates were diluted 1:10 in PBS containing 0.1% Tween 20 and
3% bovine serum albumin. Analysis of IgA antibodies in the lung
lysate was performed against B. pertussis antigens (Ptx, Prn, FHA,
and Fim2/3) and OMV B1917 as described in the section
multiplex immunoassay (MIA) for antibody response.
Splenocyte isolation
Spleen tissue was forced through a 70 mm cell strainer (BD
Falcon, BD Biosciences, USA) and washed two times with 5 ml
medium (RPMI, FCS, p/s/g) to obtain a single cell suspension.
After centrifugation (550 g, 5 min.), 1 ml shock buffer was added
to cell pellet to lyse erythrocytes. After one minute, shock
incubation was stopped by adding 25 ml medium. For cell count
(CASEY model TT, Innovatis, Roche, Germany), cells were
centrifuged and resuspended in 1 ml medium.
Cellular composition of spleen
Splenocytes (16106) were transfered to each well of a V-bottom
96-wells plate. After centrifugation (400 g, 3 min.), pellets were
washed with 100 ml FACS buffer. Fc-specific receptors on cells
were blocked with anti-CD16/CD32 in FACS buffer (2%, v/v) by
5 min. incubation on ice to prevent aspecific binding of labeled
antibodies to cells. Cells were stained after centrifugation by using
a mixture (100 ml) of labeled antibodies (30 min., 4uC). To
determine the number and identity of cells, three different panels
of labeled antibodies were used to prevent overlapping fluores-
cence spectra. Panels consisted of 1) total T-cell population (CD3),
CD4 T-cell (CD4), CD8 T-cell (CD8), early activated T-cell
(CD69), and neutrophil (Gr-1); 2) T-cell (CD3), B-cell (CD19),
monocyte (CD14), and natural killer cell (DX5); 3) T-cell (CD3),
macrophage (CD11b), DC (33D1, CD11c), MHC class II (IA/IE),
and activation marker (CD40). Data acquisition was performed
with a FACSCanto II (BD Biosciences, USA) and data analysis
was done by using FlowJo software (Tree Star Inc., USA). Debris
and dead cells were excluded by using forward/side scatter
characteristics and live/dead staining, respectively.
Stimulation of splenocytes
Splenocytes were resuspended in the culture medium IMDM
(Gibco) +8% FCS+p/s/g +20 mM b-mercaptoethanol (Sigma) and
cultured (24-wells plate; 66106 cells/well) for 7 days at 37uC in a
humidified atmosphere containing 5% CO2. Culturing was in the
presence of either the culture medium, or the culture medium
supplemented with Prn P.69 (in house expressed and purified as
described previously [116]), heat-inactivated (15 min at 95uC) Ptx
(Kaketsuken, Japan) or FHA (Kaketsuken, Japan) at a final
concentration of 1 mg/ml. Supernatants were collected after 7
days for cytokine analysis. Subsequently, cells were transferred to
U-bottom 96-wells plates (56105 cells/well) and stimulated
overnight by using the same antigens and conditions and used
for intracellular cytokine staining.
Intracellular cytokine staining
The intracellular cytokine staining was performed on 8-days
stimulated splenocytes by using a Cytofix/Cytoperm Fixation/
Permeabilization Solution Kit (BD Biosciences, USA). Briefly, cells
were incubated during the last 5 hours of stimulation with 10 mg/
ml Golgiplug (BD Biosciences), 1 mg/ml aCD28 (BD Pharmin-
gen), and 1 mg/ml aCD49d (BD Pharmingen). Cells were stained
after washing with FACS buffer with anti-CD4-Pacific blue, anti-
CD44-FITC and live/dead staining. Subsequently, the cells were
fixed, permeabilized, and stained with anti-IFNc-PE, anti-IL-5-
APC and anti-IL-17a-PerCP-Cy5.5. Data from fluorescence-
activated cells were acquired on FACS Canto II (BD Biosciences)
and analyzed with FlowJo software (Tree Star Inc., USA). CD44
was used to distinguish between naive and antigen experienced T-
cells. IL-5 was used as a Th2 cytokine, IFNc as a Th1 cytokine,
and IL-17 as a Th17 cytokine.
Multiplex immunoassay (MIA) for cytokines
Cytokine (IL-4, IL-5, IL-10, IL-13, IL-17A, TNFa, and IFNc)
concentrations (pg/ml) were determined in culture supernatants of
7 days stimulated splenocytes of individual mice by using a MIA
(Milliplex mouse cytokine 7-plex luminex kit; Merck KGaA,
Darmstadt, Germany). Cytokine (Eotaxin, G-CSF, GM-CSF,
IFN-c, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IL-
1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-9, IP-10, KC, LIF,
LIX, M-CSF, MCP-1, MIG, MIP-1a, MIP-1b, MIP-2, RANTES,
TNF-a, VEGF) concentrations (pg/ml) present in serum were
determined by using a MIA (Milliplex MAP Mouse Cytokine/
Chemokine - Premixed 32 Plex; Merck KGaA, Darmstadt,
Germany) according to the manufacturer’s instructions. Briefly,
serum/supernatant (25 ml) was diluted in supplied assay buffer (1/
1; v/v), mixed with 25 ml conjugated beads and incubated
overnight at 4uC on a plate shaker. Subsequently, beads were
washed twice with washing buffer by using a Bio-Plex handheld
magnetic washer (BioRad, USA) and incubated with 25 ml
detection antibodies (1 hour, 20–25uC) followed by incubation
with 25 ml streptavidin-phycoerythrin (30 min., 20–25uC). After
washing twice with 200 ml washing buffer, beads were resuspended
in 150 ml PBS. Samples were analyzed using a multiplex system
(Bio-Plex 200, BioRad, USA). In total, 50 beads per region were
analyzed in 100 ml sample volume. Mean fluorescence intensity
(MFI) of each cytokine was converted into pg/ml by using a
dilution series of a standard (3.2–10,000 pg/ml) and Bio-Plex
Manager software 5.0 (Bio-Rad, USA).
MIP-3a (CCL20) cytokine ELISA
Serum concentration of Macrophage Inflammatory Protein 3a
(MIP3a/CCL20) was determined by ELISA (Mouse MIP-3a
ELISA kit, RAB0061, Sigma-Aldrich, Germany) according to the
manufacturer’s manual. In short, serum (50 ml) was diluted in
assay buffer A (1/1; v/v) and incubated in an antibody-coated
ELISA plate (overnight, 4uC, gentle shaking). After washing four
times with 300 ml wash buffer, wells were incubated with 100 ml
biotinylated antibody (1 hour, room temperature, gentle shaking).
After washing four times with 300 ml wash buffer, wells were
incubated with 100 ml streptavidin solution (45 min., room
temperature, gentle shaking). After washing four times, wells were
incubated with 100 ml TMB one-step substrate reagent (30 min.,
RT) and reaction stopped with 50 ml stop solution. Finally, the
absorbance was recorded at 450 nm with a plate reader (BioTek
reader EL808, Bio-Tek) and converted to MIP-3a concentration
by using a dilution series of a standard (2.06–1,500 pg/ml) and
Gentech 5 software (BioTek).
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Statistical analysis
Cellular composition of spleen, antibody titers and cytokines
levels were analyzed by using a one-way ANOVA with multiple
comparisons of all time points post infection vs. naive mice
followed by a Dunnett t-test. ICS data was analyzed by using a
Mann-Whitney t-test. For cytokine profiling after re-stimulation of
splenocytes, MIA data was first log-transformed before t-test
analysis. In all corresponding figures, p-values are represented as
* = p,0.05, ** = p ,0.01, *** = p,0.001 and **** = p,0.0001.
Supporting Information
Figure S1 Cell type comparison analysis for lung gene
expression. Data represent gene profiles in the lung per cell type
or tissue extracted from BioGPS. Results from B-cells, mast cells,
T-cells, dendritic cells, neutrophils and lung are depicted. (Mean of
n = 3).
(TIF)
Figure S2 Cellular composition of the spleen as function
of time after B. pertussis infection. The percentage of (A)
CD14+ cells (CD14+), (B) NK-cells (DX5+), (C) macrophages
(CD11b+), (D) neutrophils (Gr-1+), (E) T-cells (CD3+, CD4+CD82
and CD8+CD42), (F) B-cells (CD19+) and (G) dendritic cells
(33D1+) in splenocytes were analyzed over time. p-values were
determined by one-way ANOVA with multiple comparison
compared to naive mice (* = p,0.05, ** = p,0.01, *** = p,
0.001 and **** = p,0.0001). (mean of n = 3). An increased
percentage of CD14+ cells (monocytes, DCs and macrophages)
was found 1 day p.i., followed by natural killer (NK) cells and
macrophages at 2 days p.i. There was a gradual increase in the
percentage of neutrophils in the spleen until 7 days p.i.
Furthermore, an increased percentage of T-cells, distinguished
by the CD3 marker, was found 2 and 4 days p.i. A similar increase
was observed for both CD4+CD82 and CD8+CD42 T-cell
subsets, indicating that this increase was not specific for either
T-helper or cytotoxic T-cells. The CD4+ cells increased signifi-
cantly 21 days p.i. and remained constant until at least 28 days p.i.
B-cells decreased during two periods: 2–4 and 10–14 days p.i.
Finally, a significant increase in percentage of DCs (33D1+) was
detected 7 days p.i.
(TIF)
Figure S3 Flow cytometric-gating strategy for CD14+,
Gr-1+, CD19+ and CD11b+ cell population analysis in
splenocytes. Each FACS plot shows results from one mouse of
the group. Per cell type, the change in numbers of cells is visible
over time for CD14+, Gr-1+, CD19+ and CD11b+ cell
populations. Time points 2 hours, 6 hours and 10 days p.i. were
excluded in this figure. (*) FACS plot for CD14+ cells at day 4 and
day 7 p.i. were manually adapted by BiExponential transforma-
tion in FlowJo for better visualization without influencing the
gating.
(TIF)
Figure S4 Flow cytometric-gating strategy for CD3+,
CD4+, CD8+, DX5+ and 33D1+ cell population analysis
in splenocytes. Each FACS plot shows results from one mouse
of the group. Per cell type, the change in numbers of cells is visible
over time for CD3+, CD4+, CD8+, DX5+ and 33D1+ cell
populations. Time points 2 hours, 6 hours and 10 days p.i. were
excluded in this figure. (*) FACS plot for 33D1+ cells at day 1, day
7 and day 14 p.i. were manually adapted by BiExponential
transformation in FlowJo for better visualization without influ-
encing the gating.
(TIF)
Figure S5 Splenic gene expression profiles of cell types
and tissues extracted from BioGPS databases. Data
represent gene profiles of the following cell types or tissues: B-
cells, neutrophils, mast cells, T-cells, macrophages, dendritic cells
(DCs), lung, lymph nodes and spleen. (Mean of n = 3).
(TIF)
Figure S6 Genes differentially regulated in both lung
and spleen. Comparison of transcriptomic data in lung and
spleen revealed an overlap of 72 genes differentially regulated in
both tissues. Genes divided in 4 groups based on expression
pattern. Functional annotation showed that genes in group 2 were
mostly involved in immunological processes. (Mean of n = 3).
(TIF)
Figure S7 IgG antibody response in serum against Ptx,
Prn, FHA and Fim2/3 after B. pertussis infection. IgG
antibody titers against four purified B. pertussis antigens; (A)
pertussis toxin (Ptx), (B) pertactin (Prn), (C) filamentous hemag-
glutinin (FHA), and (D) Fimbriae 2 and 3 (Fim2/3) were
determined using a multiplex immunoassay (mean of n = 3). The
antibody titers were determined in mouse sera 14, 21 and 28 days
after an intranasal infection with B. pertussis. No antibodies were
detected for Ptx, Prn and Fim2/3. For FHA, 1 out of 3 mice
showed induced titers antibody titers at 21 days p.i.
(TIF)
Table S1 Full list of genes expressed in the lungs. This
file contains the full list of significantly expressed genes obtained by
microarray analysis of the lungs, which can be used for additional
in-depth information for each gene. In total 558 genes were
significantly altered compared to naı¨ve mice. The expression
pattern for each gene is given including the fold changes at each
time point. In addition to the official gene symbol (obtained from
the Nimblegen array), the full gene name, synonyms and gene ID
are given. Synonyms are not given for all genes but only for genes
that were included in detail in the manuscript. Gene ID is a linked
to gene information on the NCBI website. Subsequently, there are
three columns with gene information obtained in databases; (i)
BioGPS, (ii) Gene Ontology – Biological Processes (GO-BP), (iii)
KEGG pathways. Pull-down menus can be used to search for
specific information in the full gene list. For BioGPS, information
about cell and tissue specific gene expression is given for the
following databases; B-cells (B), dendritic cells (DC), lung (Lu),
lymph node (LN), mast cells (MC), macrophages (MF), neutrophils
(N), spleen (Sp) and T-cells (T). For GO-BP the following
biological processes were included; ‘acute inflammatory response’,
‘acute-phase response’, ‘antigen processing and presentation’, ‘cell
activation’, ‘chemotaxis’, ‘defense response’, ‘immune response’,
‘inflammatory response’, ‘intracellular signaling cascade’, ‘phago-
cytosis’, ‘regulation of apoptosis’, ‘response to bacterium’ and
‘transcription’. For KEGG the following pathways were included;
‘Antigen processing and presentation’, ‘Apoptosis’, ‘B cell receptor
signaling pathway’, ‘Cell adhesion molecules (CAMs)’, ‘Chemo-
kine signaling pathway’, ‘Complement and coagulation cascades’,
‘Cytokine-cytokine receptor interaction’, ‘Endocytosis’, ‘Leukocyte
transendothelial migration’, ‘MAPK signaling pathway’, ‘NOD-
like receptor signaling pathway’ and ‘Toll-like receptor signaling
pathway’.
(XLSX)
Table S2 Full list of genes expressed in the spleen. This
file contains the full list of significantly expressed genes obtained by
microarray analysis of the spleen, which can be used for additional
in-depth information for each gene. In total 798 genes were
significantly altered compared to naı¨ve mice. The expression
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pattern for each gene is given including the fold changes at each
time point. In addition to the official gene symbol (obtained from
the Nimblegen array), the full gene name, synonyms and gene ID
are given. Synonyms are not given for all genes but only for genes
that were included in detail in the manuscript. Gene ID is a linked
to gene information on the NCBI website. Subsequently, there are
three columns with gene information obtained in databases; (i)
BioGPS, (ii) Gene Ontology – Biological Processes (GO-BP), (iii)
KEGG pathways. Pull-down menus can be used to search for
specific information in the full gene list. For BioGPS, information
about cell and tissue specific gene expression is given for the
following databases; B-cells (B), dendritic cells (DC), lung (Lu),
lymph node (LN), mast cells (MC), macrophages (MF), neutrophils
(N), spleen (Sp) and T-cells (T). For GO-BP the following
biological processes were included; ‘acute inflammatory response’,
‘antigen processing and presentation’, ‘cell activation’, ‘chemotax-
is’, ‘chromatin assembly’, ‘defense response’, ‘hemopoiesis’,
‘immune response’, ‘inflammatory response’, ‘intracellular signal-
ing cascade’, ‘regulation of apoptosis’, ‘response to bacterium’ and
‘transcription’. For KEGG the following pathways were included;
‘Antigen processing and presentation’, ‘Apoptosis’, ‘B cell receptor
signaling pathway’, ‘Cell adhesion molecules (CAMs)’, ‘Chemo-
kine signaling pathway’, ‘Complement and coagulation cascades’,
‘Cytokine-cytokine receptor interaction’, ‘Endocytosis’, ‘Leukocyte
transendothelial migration’, ‘MAPK signaling pathway’, ‘NOD-
like receptor signaling pathway’ and ‘Toll-like receptor signaling
pathway’.
(XLSX)
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